Off-Label Marketing MDL Over Amgen Drugs Nixed
In a major win for Amgen Inc., a judge has dismissed with prejudice the entirety of a proposed class action by a group of health benefit plans accusing the company of...To view the full article, register now.
Already a subscriber? Click here to view full article